Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH), 43180-43181 [2010-17545]
Download as PDF
<![CDATA[
43180
Federal Register / Vol. 75, No. 141 / Friday, July 23, 2010 / Notices
chosen to use conveners as a vehicle to
recruit physician practices for
participation in the demonstration
because it is expected that the likely
applicants for the convener have well
developed relationships (or the ability
to establish) with a significant network
of physicians that could be potential
applicants for participation in the
demonstration. Therefore, conveners
would be highly effective at providing a
robust panel of physicians that could
satisfy the selection requirements
outlined in the statute. Conveners must
also disclose in the application whether
the DSS may be retained by the
participating practice after the
demonstration is concluded and
whether the DSS may be used to order
items and services other than the subject
imaging services.
Applicants must submit their
applications in the standard format
outlined in CMS’ Medicare Waiver
Demonstration Application and MID
solicitation in order to be considered for
review by the technical review panel.
Applications not received in this format
will not be considered for review.
The Medicare Waiver Demonstration
Application can be found electronically
at: https://www.cms.hhs.gov/cmsforms/
downloads/cms10069.pdf.
For specific details regarding the MID,
please refer to the solicitation on the
CMS Web site at: https://www.cms.hhs.
gov/DemoProjectsEvalRpts/downloads/
Medicare_Imaging_Demonstration.pdf.
II. Collection of Information
Requirements
Section 135(b)(4)(A) of the MIPPA
(Pub. L. 110–275) exempts this
demonstration from the Chapter 35 of
Title 44 of the United States Code;
however, the collection form entitled
‘‘Medicare Demonstration Waiver
Application’’ is currently approved
under OMB control number 0938–0880.
WReier-Aviles on DSKGBLS3C1PROD with NOTICES
(Catalog of Federal Domestic Assistance
Program No. 93.773, Medicare—Hospital
Insurance; and Program No. 93.774,
Medicare—Supplementary Medical
Insurance Program)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Centers for Disease Control and
Prevention
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel, Research Centers in Trauma, Burn,
and Peri-Operative Injury (P50).
Date: August 17, 2010.
Time: 1 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Natcher Building, 45 Center Drive,
Room 3AN12B, Bethesda, MD 20892.
Contact Person: Margaret J. Weidman, PhD,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3AN18B, Bethesda, MD
20892, 301–594–3663,
weidmanma@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
Dated: July 19, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
Dated: April 1, 2010.
Charlene Frizzera,
Acting Administrator, Centers for Medicare
& Medicaid Services.
[FR Doc. 2010–18088 Filed 7–22–10; 8:45 am]
BILLING CODE 4140–01–P
[FR Doc. 2010–18139 Filed 7–22–10; 8:45 am]
BILLING CODE 4120–01–P
VerDate Mar<15>2010
15:15 Jul 22, 2010
Jkt 220001
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
Advisory Board on Radiation and
Worker Health (ABRWH or Advisory
Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), and pursuant to the
requirements of 42 CFR 83.15(a), the
Centers for Disease Control and
Prevention (CDC), announces the
following meeting of the
aforementioned committee:
Board Public Meeting Times and Dates (All
times are Eastern Time):
8:15 a.m.–3 p.m., August 10, 2010.
8:15 a.m.–4:15 p.m., August 11, 2010.
8:15 a.m.–12 p.m., August 12, 2010.
Public Comment Times and Dates (All times
are Eastern Time):
3:30 p.m.–5 p.m.,* August 10, 2010.
4:30 p.m.–6 p.m.,* August 11, 2010.
* Please note that the public comment
periods may end before the times indicated,
following the last call for comments.
Members of the public who wish to provide
public comment should plan to attend public
comment sessions at the start times listed.
Place: Shilo Inn Suites Hotel, 780 Lindsay
Blvd., Idaho Falls, Idaho; Phone: 208–523–
0088; Fax: 208–522–7420. Audio Conference
Call via FTS Conferencing. The USA toll free
dial in number is 1–866–659–0537 with a
pass code of 9933701.
Status: Open to the public, limited only by
the space available. The meeting space
accommodates approximately 150 people.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation Program
(EEOICP) Act of 2000 to advise the President
on a variety of policy and technical functions
required to implement and effectively
manage the new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines which
have been promulgated by the Department of
Health and Human Services (HHS) as a final
rule, advice on methods of dose
reconstruction which have also been
promulgated by HHS as a final rule, advice
on the scientific validity and quality of dose
estimation and reconstruction efforts being
performed for purposes of the compensation
program, and advice on petitions to add
classes of workers to the Special Exposure
Cohort (SEC).
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS, which
subsequently delegated this authority to the
CDC. NIOSH implements this responsibility
for CDC. The charter was issued on August
3, 2001, renewed at appropriate intervals,
and will expire on August 3, 2011.
Purpose: This Advisory Board is charged
with (a) Providing advice to the Secretary,
E:\FR\FM\23JYN1.SGM
23JYN1
WReier-Aviles on DSKGBLS3C1PROD with NOTICES
Federal Register / Vol. 75, No. 141 / Friday, July 23, 2010 / Notices
HHS, on the development of guidelines
under Executive Order 13179; (b) providing
advice to the Secretary, HHS, on the
scientific validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at any
Department of Energy facility who were
exposed to radiation but for whom it is not
feasible to estimate their radiation dose, and
on whether there is reasonable likelihood
that such radiation doses may have
endangered the health of members of this
class.
Matters to be Discussed: The agenda for the
Advisory Board meeting includes: NIOSH
Program Update and Program Evaluation
Plans; Department of Labor (DOL) Program
Update; Department of Energy (DOE)
Program Update; Idaho National Laboratory
Update; Board Consideration of Discrete
Incidents/Health Endangerment; Special
Exposure Cohort (SEC) petitions for: Mound
Plant, Linde Ceramics Plant (Tonawanda,
New York), Ames Laboratory (Ames, Iowa),
Revere Copper and Brass (Detroit, Michigan),
General Electric (Evendale, Ohio), and
Metallurgical Laboratory (Chicago, Illinois);
Science Update, SEC Petition Status Updates;
Subcommittee and Work Group Reports; and
Board Working Time.
The agenda is subject to change as
priorities dictate.
In the event an individual cannot attend,
written comments may be submitted in
accordance with the redaction policy
provided below. Any written comments
received will be provided at the meeting and
should be submitted to the contact person
below well in advance of the meeting.
Policy on Redaction of Board Meeting
Transcripts (Public Comment), (1) If a person
making a comment gives his or her name, no
attempt will be made to redact that name. (2)
NIOSH will take reasonable steps to ensure
that individuals making public comment are
aware of the fact that their comments
(including their name, if provided) will
appear in a transcript of the meeting posted
on a public Web site. Such reasonable steps
include: (a) A statement read at the start of
each public comment period stating that
transcripts will be posted and names of
speakers will not be redacted; (b) A printed
copy of the statement mentioned in (a) above
will be displayed on the table where
individuals sign up to make public comment;
(c) A statement such as outlined in (a) above
will also appear with the agenda for a Board
Meeting when it is posted on the NIOSH Web
site; (d) A statement such as in (a) above will
appear in the Federal Register Notice that
announces Board and Subcommittee
meetings. (3) If an individual in making a
statement reveals personal information (e.g.,
medical information) about themselves that
information will not usually be redacted. The
NIOSH FOIA coordinator will, however,
review such revelations in accordance with
the Freedom of Information Act and the
Federal Advisory Committee Act and if
deemed appropriate, will redact such
information. (4) All disclosures of
information concerning third parties will be
redacted. (5) If it comes to the attention of the
VerDate Mar<15>2010
15:15 Jul 22, 2010
Jkt 220001
DFO that an individual wishes to share
information with the Board but objects to
doing so in a public forum, the DFO will
work with that individual, in accordance
with the Federal Advisory Committee Act, to
find a way that the Board can hear such
comments.
Contact Person for More Information:
Theodore Katz, M.P.A., Executive Secretary,
NIOSH, CDC, 1600 Clifton Road, MS E–20,
Atlanta, GA 30333, Telephone (513) 533–
6800, Toll Free 1 (800) CDC–INFO, E-mail
ocas@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register Notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: July 13, 2010.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2010–17545 Filed 7–22–10; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; T Cell Receptor Signaling
Network.
Date: August 19, 2010.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge 6700, 6700B Rockledge Drive,
Bethesda, MD 20817. (Telephone Conference
Call)
Contact Person: Raymond Richard Schleef,
PhD, Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, National Institutes of Health/
NIAID, 6700B Rockledge Drive, MSC 7616,
PO 00000
Frm 00045
Fmt 4703
Sfmt 9990
43181
Bethesda, MD 20892–7616, (301) 451–3679,
schleefrr@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: July 19, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–18058 Filed 7–22–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, Pathogenesis/Immunology
of Tularemia.
Date: August 17, 2010.
Time: 8:30 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817.
(Telephone Conference Call)
Contact Person: Annie Walker-Abbey, PhD,
Scientific Review Officer, Scientific Review
Program, NIAID/NIH/DHHS, 6700B
Rockledge Drive, Rm 3126, MSC–7616,
Bethesda, MD 20892–7616, 301–451–2671,
aabbey@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: July 19, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–18057 Filed 7–22–10; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\23JYN1.SGM
23JYN1
]]>Agencies
[Federal Register Volume 75, Number 141 (Friday, July 23, 2010)]
[Notices]
[Pages 43180-43181]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-17545]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Board on Radiation and Worker Health (ABRWH or Advisory
Board), National Institute for Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), and pursuant to the requirements of 42
CFR 83.15(a), the Centers for Disease Control and Prevention (CDC),
announces the following meeting of the aforementioned committee:
Board Public Meeting Times and Dates (All times are Eastern Time):
8:15 a.m.-3 p.m., August 10, 2010.
8:15 a.m.-4:15 p.m., August 11, 2010.
8:15 a.m.-12 p.m., August 12, 2010.
Public Comment Times and Dates (All times are Eastern Time):
3:30 p.m.-5 p.m.,* August 10, 2010.
4:30 p.m.-6 p.m.,* August 11, 2010.
* Please note that the public comment periods may end before the
times indicated, following the last call for comments. Members of
the public who wish to provide public comment should plan to attend
public comment sessions at the start times listed.
Place: Shilo Inn Suites Hotel, 780 Lindsay Blvd., Idaho Falls,
Idaho; Phone: 208-523-0088; Fax: 208-522-7420. Audio Conference Call
via FTS Conferencing. The USA toll free dial in number is 1-866-659-
0537 with a pass code of 9933701.
Status: Open to the public, limited only by the space available.
The meeting space accommodates approximately 150 people.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program (EEOICP) Act of
2000 to advise the President on a variety of policy and technical
functions required to implement and effectively manage the new
compensation program. Key functions of the Advisory Board include
providing advice on the development of probability of causation
guidelines which have been promulgated by the Department of Health
and Human Services (HHS) as a final rule, advice on methods of dose
reconstruction which have also been promulgated by HHS as a final
rule, advice on the scientific validity and quality of dose
estimation and reconstruction efforts being performed for purposes
of the compensation program, and advice on petitions to add classes
of workers to the Special Exposure Cohort (SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to the CDC. NIOSH implements
this responsibility for CDC. The charter was issued on August 3,
2001, renewed at appropriate intervals, and will expire on August 3,
2011.
Purpose: This Advisory Board is charged with (a) Providing
advice to the Secretary,
[[Page 43181]]
HHS, on the development of guidelines under Executive Order 13179;
(b) providing advice to the Secretary, HHS, on the scientific
validity and quality of dose reconstruction efforts performed for
this program; and (c) upon request by the Secretary, HHS, advise the
Secretary on whether there is a class of employees at any Department
of Energy facility who were exposed to radiation but for whom it is
not feasible to estimate their radiation dose, and on whether there
is reasonable likelihood that such radiation doses may have
endangered the health of members of this class.
Matters to be Discussed: The agenda for the Advisory Board
meeting includes: NIOSH Program Update and Program Evaluation Plans;
Department of Labor (DOL) Program Update; Department of Energy (DOE)
Program Update; Idaho National Laboratory Update; Board
Consideration of Discrete Incidents/Health Endangerment; Special
Exposure Cohort (SEC) petitions for: Mound Plant, Linde Ceramics
Plant (Tonawanda, New York), Ames Laboratory (Ames, Iowa), Revere
Copper and Brass (Detroit, Michigan), General Electric (Evendale,
Ohio), and Metallurgical Laboratory (Chicago, Illinois); Science
Update, SEC Petition Status Updates; Subcommittee and Work Group
Reports; and Board Working Time.
The agenda is subject to change as priorities dictate.
In the event an individual cannot attend, written comments may
be submitted in accordance with the redaction policy provided below.
Any written comments received will be provided at the meeting and
should be submitted to the contact person below well in advance of
the meeting.
Policy on Redaction of Board Meeting Transcripts (Public
Comment), (1) If a person making a comment gives his or her name, no
attempt will be made to redact that name. (2) NIOSH will take
reasonable steps to ensure that individuals making public comment
are aware of the fact that their comments (including their name, if
provided) will appear in a transcript of the meeting posted on a
public Web site. Such reasonable steps include: (a) A statement read
at the start of each public comment period stating that transcripts
will be posted and names of speakers will not be redacted; (b) A
printed copy of the statement mentioned in (a) above will be
displayed on the table where individuals sign up to make public
comment; (c) A statement such as outlined in (a) above will also
appear with the agenda for a Board Meeting when it is posted on the
NIOSH Web site; (d) A statement such as in (a) above will appear in
the Federal Register Notice that announces Board and Subcommittee
meetings. (3) If an individual in making a statement reveals
personal information (e.g., medical information) about themselves
that information will not usually be redacted. The NIOSH FOIA
coordinator will, however, review such revelations in accordance
with the Freedom of Information Act and the Federal Advisory
Committee Act and if deemed appropriate, will redact such
information. (4) All disclosures of information concerning third
parties will be redacted. (5) If it comes to the attention of the
DFO that an individual wishes to share information with the Board
but objects to doing so in a public forum, the DFO will work with
that individual, in accordance with the Federal Advisory Committee
Act, to find a way that the Board can hear such comments.
Contact Person for More Information: Theodore Katz, M.P.A.,
Executive Secretary, NIOSH, CDC, 1600 Clifton Road, MS E-20,
Atlanta, GA 30333, Telephone (513) 533-6800, Toll Free 1 (800) CDC-
INFO, E-mail ocas@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: July 13, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2010-17545 Filed 7-22-10; 8:45 am]
BILLING CODE 4163-18-P
